89bio (ETNB) Competitors $11.08 +0.12 (+1.05%) Closing price 03:59 PM EasternExtended Trading$10.95 -0.13 (-1.13%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ETNB vs. KRYS, SWTX, BHVN, RXRX, PTCT, OGN, RARE, ALVO, RNA, and ADMAShould you be buying 89bio stock or one of its competitors? The main competitors of 89bio include Krystal Biotech (KRYS), SpringWorks Therapeutics (SWTX), Biohaven (BHVN), Recursion Pharmaceuticals (RXRX), PTC Therapeutics (PTCT), Organon & Co. (OGN), Ultragenyx Pharmaceutical (RARE), Alvotech (ALVO), Avidity Biosciences (RNA), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry. 89bio vs. Krystal Biotech SpringWorks Therapeutics Biohaven Recursion Pharmaceuticals PTC Therapeutics Organon & Co. Ultragenyx Pharmaceutical Alvotech Avidity Biosciences ADMA Biologics 89bio (NASDAQ:ETNB) and Krystal Biotech (NASDAQ:KRYS) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability. Which has better earnings & valuation, ETNB or KRYS? Krystal Biotech has higher revenue and earnings than 89bio. 89bio is trading at a lower price-to-earnings ratio than Krystal Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio89bioN/AN/A-$142.19M-$2.91-3.81Krystal Biotech$290.52M18.60$10.93M$2.9962.83 Does the MarketBeat Community prefer ETNB or KRYS? Krystal Biotech received 181 more outperform votes than 89bio when rated by MarketBeat users. Likewise, 67.51% of users gave Krystal Biotech an outperform vote while only 64.00% of users gave 89bio an outperform vote. CompanyUnderperformOutperform89bioOutperform Votes11264.00% Underperform Votes6336.00% Krystal BiotechOutperform Votes29367.51% Underperform Votes14132.49% Do insiders & institutionals believe in ETNB or KRYS? 86.3% of Krystal Biotech shares are held by institutional investors. 2.8% of 89bio shares are held by company insiders. Comparatively, 14.1% of Krystal Biotech shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts recommend ETNB or KRYS? 89bio presently has a consensus target price of $31.43, indicating a potential upside of 183.78%. Krystal Biotech has a consensus target price of $210.00, indicating a potential upside of 11.79%. Given 89bio's higher possible upside, research analysts plainly believe 89bio is more favorable than Krystal Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 89bio 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.89Krystal Biotech 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more risk & volatility, ETNB or KRYS? 89bio has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Krystal Biotech has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Does the media favor ETNB or KRYS? In the previous week, Krystal Biotech had 28 more articles in the media than 89bio. MarketBeat recorded 32 mentions for Krystal Biotech and 4 mentions for 89bio. Krystal Biotech's average media sentiment score of 0.75 beat 89bio's score of 0.66 indicating that Krystal Biotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 89bio 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Krystal Biotech 9 Very Positive mention(s) 7 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ETNB or KRYS more profitable? Krystal Biotech has a net margin of 30.69% compared to 89bio's net margin of 0.00%. Krystal Biotech's return on equity of 11.41% beat 89bio's return on equity.Company Net Margins Return on Equity Return on Assets 89bioN/A -59.58% -52.21% Krystal Biotech 30.69%11.41%10.40% SummaryKrystal Biotech beats 89bio on 14 of the 16 factors compared between the two stocks. Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ETNB vs. The Competition Export to ExcelMetric89bioPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.18B$7.04B$5.78B$8.98BDividend YieldN/A2.87%4.78%3.85%P/E Ratio-3.816.1326.4618.82Price / SalesN/A313.78457.6880.73Price / CashN/A67.8344.0437.47Price / Book1.936.747.634.64Net Income-$142.19M$138.11M$3.18B$245.69M7 Day Performance4.78%-2.02%-1.82%-2.63%1 Month Performance68.31%-1.54%0.22%-2.37%1 Year Performance5.88%-3.14%17.49%13.65% 89bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ETNB89bio3.1156 of 5 stars$11.08+1.0%$31.43+183.8%+10.8%$1.18BN/A-3.8140Analyst ForecastKRYSKrystal Biotech4.4767 of 5 stars$153.24-1.6%$206.67+34.9%+63.6%$4.41B$50.70M86.58210Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageSWTXSpringWorks Therapeutics1.2527 of 5 stars$57.43-2.0%$70.83+23.3%+22.8%$4.27B$5.45M-14.80230Earnings ReportAnalyst ForecastInsider TradeNews CoverageBHVNBiohaven3.3782 of 5 stars$41.45-0.8%$63.15+52.4%-15.8%$4.19BN/A-4.43239Short Interest ↓RXRXRecursion Pharmaceuticals1.5231 of 5 stars$10.53+23.9%$8.75-16.9%-17.8%$4.11B$64.60M-6.88400High Trading VolumePTCTPTC Therapeutics3.6197 of 5 stars$51.82+4.3%$58.85+13.6%+93.9%$4.00B$937.82M-8.721,410Analyst ForecastNews CoverageOGNOrganon & Co.4.8637 of 5 stars$15.30-6.3%$20.80+36.0%-15.2%$3.94B$6.26B3.0310,000RAREUltragenyx Pharmaceutical4.6097 of 5 stars$42.49-2.4%$92.43+117.5%-7.1%$3.92B$434.25M-6.571,276Analyst ForecastALVOAlvotech2.6284 of 5 stars$12.99+1.6%$18.00+38.6%-26.7%$3.92B$391.87M-7.021,026News CoverageRNAAvidity Biosciences1.6234 of 5 stars$32.31-2.2%$65.80+103.7%+132.7%$3.85B$9.56M-11.22190ADMAADMA Biologics3.5404 of 5 stars$15.90-1.1%$21.25+33.6%+212.2%$3.76B$258.21M56.79530 Related Companies and Tools Related Companies Krystal Biotech Alternatives SpringWorks Therapeutics Alternatives Biohaven Alternatives Recursion Pharmaceuticals Alternatives PTC Therapeutics Alternatives Organon & Co. Alternatives Ultragenyx Pharmaceutical Alternatives Alvotech Alternatives Avidity Biosciences Alternatives ADMA Biologics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ETNB) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 89bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ETNB Stock Alerts